bioengineer.org /6 days ago

Engineered Adeno-Associated Virus Enables Efficient In Vivo Immune Cell Programming

A directed-evolution adeno-associated virus capsid targeting CD7 achieves robust gene delivery and therapeutic chimeric antigen receptor cell engineering in living animal models.

Read source
bioengineer.org /1 month ago

Stem Cell Feeder Platforms Boost Natural Killer Cells for Cancer Immunotherapy

Researchers have developed engineered feeder cells derived from induced pluripotent stem cells that prolong the survival and boost the killing power of natural killer cells, offeri...

Read source
fightaging.org /1 month ago

Creation of Chimeric Antigen Receptor Natural Killer Cells in Situ via Messenger RNA Therapy

Messenger RNA (mRNA) can be delivered into tissues and cells by encapsulating it into lipid nanoparticles (LNPs), and then injecting the nanoparticles. A target cell engulfs a LNP,...

Read source
multiple-sclerosis-research.org /1 month ago

CAR-T cell therapy

In this study the people had been treated with anti-CD20 antibodies and they had no cells when treatment was started and they B cells began to recover by 12 weeks and back to norma...

Read source
scitechdaily.com /4 weeks ago

MIT Scientists Reprogram Immune Cells Inside the Body To Destroy Cancer

Natural killer cells reprogrammed inside mice eliminated lymphoma tumors and helped damaged livers heal, though whether this approach could help people with cancer or autoimmune di...

Read source
genengnews.com /1 week ago

Therapeutic Immune Manipulation

Next-generation immunotherapy exploits diverse immune populations to address the challenges that CAR T-cell therapy faces. The post Therapeutic Immune Manipulation appeared first o...

Read source
timesofindia.indiatimes.com /1 month ago

Stanford blood cancer transplant therapy reaches first commercial patient

In a remarkable advancement, Stanford researchers have unveiled Orca-T therapy, which has recently received FDA approval. After two decades of rigorous development, this innovative...

Read source
biopharmadive.com /1 month ago

An ‘off-the-shelf’ CAR-T therapy from Adicet shows promise against lupus

Data from an early trial showed the company’s “gamma delta” cell therapy surpassed benchmarks set by personalized CAR-T treatments tested in lupus.

Read source
sciencedaily.com /2 weeks ago

MIT scientists turn immune cells into cancer killers inside the body

MIT scientists have developed nanoparticles that reprogram immune cells directly inside the body to attack cancer and harmful immune cells, eliminating tumors and reversing liver d...

Read source
medicalxpress.com /3 weeks ago

Smarter CAR-T cells could beat a deadly pediatric brain cancer

Scientists at UC San Francisco have engineered CAR-T cells that stay dormant until they reach the brain, where they switch on and destroy tumor cells. In mice, these CAR-T cells we...

Read source
nephronpower.com /3 weeks ago

Topic Discussions: T cell engagers and use in Solid Organ Transplants

Data on bispecific T-cell engagers in solid organ transplant (SOT) recipients are limited to a few case reports and small case series. No prospective trials, pooled analyses, or gu...

Read source
bioengineer.org /1 month ago

Hidden armies inside glioblastoma: exhausted T cells hint at new immunotherapy routes

Single-cell analysis of 56 glioblastoma tumors reveals that T-cell-rich cases harbor clonally expanded, LAG3-high CD8 T cells that may be tumor-reactive, opening new avenues for im...

Read source
bioengineer.org /1 month ago

Lipid Nanoparticles Deliver CAR Instructions to T Cells Without Viruses

Researchers have engineered a custom ionizable lipid nanoparticle that delivers CAR-encoding mRNA into human T cells with over 90 percent efficiency, producing potent antitumor act...

Read source
qchron.com /2 weeks ago

Creative Biogene Launches Lentiviral Vector-Based In Vivo CAR-T Development to Pioneer the Future of Cancer Therapy

Creative Biogene proudly announces the launch of its flagship lentiviral vector-based in vivo CAR-T development services, aimed at revolutionizing cancer treatments through precisi...

Read source
bioengineer.org /1 month ago

Gamma Delta T Cells Blur the Line Between Innate and Adaptive Immunity

New research in Nature shows that gamma delta T cells rely on their adaptive T cell receptors in real time to mount rapid, innate-like tissue surveillance and anti-tumour responses...

Read source
fightaging.org /1 month ago

Where Next For Present Stem Cell Therapies?

First generation stem cell therapies have become widespread; they are readily accessed in medical tourism clinics, and are also available for a range of issues in more regulated pa...

Read source
multiple-sclerosis-research.org /1 month ago

B cell therapy as an anti-EBV therapy

D’Orso S, Picozza M, Guerrera G, Verdiani A, Pirronello M, Misiti A, Olivieri E, Corbisiero S, Angelini DF, Ingrascì A, Giardina E, Ruggieri S, Tortorella C, Gasperini C, Buscarinu...

Read source
scitechdaily.com /2 weeks ago

Breakthrough Cancer Treatment Wipes Out Deadly Brain Tumors in Every Mouse Tested

A new approach to engineering immune cells has shown remarkable success against a deadly childhood brain cancer in mice. An experimental immune cell therapy has completely eliminat...

Read source
newatlas.com /1 month ago

An overlooked immune cell offers a way to treat deadliest lung cancers

An overlooked population of immune cells could offer a new way to attack one of the deadliest forms of lung cancer.Continue ReadingCatego...

Read source
gizmodo.com /1 month ago

Living Drugs Transformed Blood Cancer Treatment—and That’s Just the Beginning

Renier Brentjen, an early pioneer of CAR T cell therapy, is working on the next generation of these living drugs that can hopefully treat solid tumors, too.

Read source
medcitynews.com /1 week ago

Nkarta Autoimmune Disease Cell Therapy’s First Human Data Show Safety, Signs of Efficacy

Nkarta will present initial clinical data for its natural killer cell therapy in two disorders, myositis and systemic sclerosis, during the American College of Rheumatology annual...

Read source
multiplesclerosisnewstoday.com /3 weeks ago

Experimental CAR T-cell therapy shows promise in early MS trial

Most people with relapsing or progressive forms of multiple sclerosis (MS) had stable or improved disability scores, along with signs of reduced disease activity, after receiving a...

Read source
e.vnexpress.net /1 week ago

Vietnamese hospital receives Japanese cell therapy technology for cancer and chronic disease treatment

Tam Anh General Hospital has completed an exclusive technology transfer from Japan's Grandsoul Medical Group covering immune cell and stem cell technologies being explored for trea...

Read source
journals.plos.org /1 month ago

Natural killer cell receptor signaling and activation depend on cell cycle stages

by Darren Wethington, Indrani Nayak, Helle Jensen, William C. Stewart, Oscar A. Aguilar, Shih-Yu Chen, Garry P. Nolan, Gregory K. Behbehani, Lewis L. Lanier, Jayajit Das Natural K...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.